Chile has selected China”s vaccine company, Sinovac Biotech, as the exclusive supplier of its influenza vaccines for 2026 — awarding the company a contract for more than 8 million doses, Sinovac said in a statement on…
Category: 6. Health
-
Most of us are prone to it
Stress usually adds to pain, it’s a well-known fact.
But a new…
Continue Reading
-
When Twinkle Khanna opened up on melasma, calling it a ‘bin bulaya mehman’: here’s what we know on the condition
In 2023, former actor turned author Twinkle Khanna, revealed her experience with melasma, calling it an “uninvited guest” that appeared during her second pregnancy. Talking about it on her Tweak video, the now 52-year-old said that she…
Continue Reading
-
A smarter way to screen for breast cancer is emerging
A large new study suggests that tailoring breast cancer screening to a woman’s individual risk may be safer and more effective than relying on routine annual mammograms for everyone. By matching screening frequency to personal risk levels,…
Continue Reading
-
Drug-Resistant Fungus Candida Auris Spreads Globally as Researchers Seek New Treatments
A deadly, drug-resistant fungus, Candida auris, is spreading globally, with 7,000 US cases in 2025. Researchers warn of limited treatments but see hope in new studies targeting its biology.
ERBIL (Kurdistan24) — A deadly and…
Continue Reading
-
When measles made a comeback in Mesa County | Western Colorado
It was a comeback year in 2025 in many ways, from the resurgence of ’90s fashion, such as bootcut jeans and denim-on-denim, to the return of wired headphones.
But 2025 also saw the revival of less desirable relics, like the measles, which…
Continue Reading
-
AgenT-797 (iNKT): What Patients Need to Know About This New Cancer Immunotherapy
AgenT-797 is an experimental cancer treatment being studied in clinical trials. It belongs to a newer category of treatments called cellular immunotherapy, which uses immune cells to help the body recognize and fight cancer….
Continue Reading
-
AgenT-797 (iNKT): Uses in Cancer, Side Effects, Dosages, Expectations, and Clinical Trial Evidence
Cellular immunotherapy has traditionally centered on autologous, genetically engineered T-cell platforms, which—despite transformative efficacy in selected settings—are limited by toxicity, manufacturing complexity, and…
Continue Reading
-
Ablation Success Rate for Liver Cancer. What Patients Need to Know in 2026
Liver cancer treatment has evolved significantly over the past two decades, and tumor ablation has become an important option for selected patients—especially those diagnosed at an early stage. For many people who are not…
Continue Reading